Initiation of monomorphic ventricular tachycardia: electrophysiological, clinical features, and drug therapy in patients with implantable defibrillators.
At least 2 distinct patterns of sustained monomorphic ventricular tachycardia (MVT) have been ascribed during analysis of stored intracardiac electrograms retrieved from implantable cardioverter defibrillators and Holter recordings in patients with ventricular arrhythmia. We aimed to investigate the electrophysiological features of MVT with different initiation patterns in patients with implantable cardioverter defibrillators and to assess whether there is a relationship of the initiation patterns of sustained MVT with clinical characteristics and efficacy of antiarrhythmic therapy. Seventy-four stored intracardiac electrograms in 21 patients (mean age of 68.2 +/- 4.2 years) with MVT were evaluated. Cardiovascular diagnosis included coronary artery disease in 85.7% of the patients. All MVT episodes were classified as those initiating with ventricular premature beats (nonsudden onset MVT) and those without ventricular ectopy preceding tachycardia (sudden onset MVT). There was significant difference in left ventricular ejection fraction between MVTs with different initiation pattern, being the lower in those with nonsudden onset (33.6% +/- 38.4% vs. 38.4 +/- 7.0%, P <.04). Ventricular tachycardia cycle length was shorter in group of MVT with nonsudden onset as compared with sudden onset (338.5% +/- 48.1% vs. 376.8% +/- 57.0%, P <.02). Tachycardia with sudden onset was associated with shorter preceding RR interval than tachycardia with nonsudden onset (821.8 +/- 136.2% vs. 748.7 +/- 107.7%, P <.01). There were no significant differences in the type of antiarrhythmic drug therapy used between groups (P >.05). Monomorphic ventricular tachycardias with nonsudden onset occurred more frequently than with sudden onset, without precipitating RR cycles shortening, are faster in rate, associating with lower ejection fraction. Monomorphic ventricular tachycardias with sudden onset are characterized by preceding shortening of RR intervals, slower cycle length, and less worsening of ejection fraction.
Gorenek
Bulent
B
Cardiology Department, Osmangazi University, Eskisehir, Turkey. bgorenek@hotmail.com
Kudaiberdieva
Gulmira
G
Birdane
Alpaslan
A
Goktekin
Omer
O
Cavusoglu
Yuksel
Y
Bakar
Salih
S
Unalir
Ahmet
A
Ata
Necmi
N
Timuralp
Bilgin
B
D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001341:Autonomic Nervous System / Q000503:physiopathology; D017147:Defibrillators, Implantable; D004562:Electrocardiography / Q000379:methods*; D006801:Humans; D013318:Stroke Volume / Q000187:drug effects / Q000502:physiology; D017180:Tachycardia, Ventricular / Q000188:drug therapy / Q000503:physiopathology* / Q000628:therapy*
D000889:Anti-Arrhythmia Agents